Leonel Bracco

Leonel Bracco

Auto-generated profile, based on publicly available information

Leonel Bracco

Instituto de Investigaciones Biotecnológicas (IIB) — Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ARAlejandro D. Ricci
Alejandro D. Ricci
LBLeonel Bracco
Leonel Bracco
ESEmir Salas-Sarduy
Emir Salas-Sarduy
JRJanine M. Ramsey
Janine M. Ramsey
MNMelissa S. Nolan
Melissa S. Nolan
FAFernán Agüero
Fernán Agüero
During an infection the immune system produces pathogen-specific antibodies. These antibody repertoires become specific to the history of infections and represent a rich source of diagnostic markers. However, the specificities of these antibodies are mostly unknown. Here, using high-density peptide arrays we examined the human antibody repertoires of Chagas disease patients. Chagas disease is a neglected disease caused by Trypanosoma cruzi, a protozoan parasite that evades immune mediated elimination and mounts long-lasting chronic infections. We describe a proteome-wide search for antigens, characterised their linear epitopes, and show their reactivity on 71 individuals from diverse human populations. Using single-residue mutagenesis we revealed the core functional residues for 232 of these epitopes. Finally, we show the diagnostic performance of identified antigens on challenging samples. These datasets enable the study of the Chagas antibody repertoire at an unprecedented depth and granularity, while also providing a rich source of serological biomarkers.

23 August 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
ARAlejandro D. Ricci
Alejandro D. Ricci
LBLeonel Bracco
Leonel Bracco
JRJanine M Ramsey
Janine M Ramsey
MGMelissa Garcia
Melissa Garcia
MLMary Lynn
Mary Lynn
FAFernán Agüero
Fernán Agüero
During an infection, the immune system produces pathogen-specific antibodies. With time, these antibody repertoires become specific to the history of infections and represent a rich source of diagnostic markers. However, the specificities of these antibodies are mostly unknown. Here, using high-density peptide arrays we examined the specificities of human antibody repertoires of Chagas disease patients. Chagas disease is a neglected disease caused by Trypanosoma cruzi, a protozoan parasite that evades immune mediated elimination and mounts long-lasting chronic infections. We describe here the first proteome-wide search for antigens and epitopes and their seroprevalence at the individual level and across human populations. In a first discovery screening of 2.84 million short peptides spanning two T. cruzi proteomes we found 3,868 distinct antigenic protein regions. Further analysis of repertoires from 71 individuals provided information on their seroprevalence and showed a large fraction of private epitopes of low seroprevalence (<20%), and novel high seroprevalence antigens. Using single-residue mutagenesis we found the core epitopes required for antibody binding for 232 of these epitopes. These datasets enable the study of the Chagas antibody repertoire at an unprecedented depth and granularity, while also providing a rich source of novel serological biomarkers. IMPACT STATEMENT: This work reveals the diversity and extent of antibody specificities in Chagas Disease and provides a wealth of well-defined antigenic markers for diagnosis and development of serological applications for this neglected infectious disease.